Skip to main content
. 2021 Oct 31;3(5):335–342. doi: 10.35772/ghm.2021.01079

Figure 4.

Figure 4.

Development of the number of issued hepatitis treatment beneficiary certificates. In the roughly 5 years since interferon-free therapy was approved in Japan for chronic hepatitis C, the number of certificates regarding IFN-free therapy have decreased. IFN: interferon, NA: nucleic acid analogue.